#crescolabs

[lgbtstoner]

Indica Sampling 🍁🍃top left: blueberry cookies, top right: original glue (gg#4), bottom left: grandpa’s breath, bottom right: motor’s breath

[cannabisnewstoday]

Lake View pot shop workers become first to unionize in Illinois

When the 40 employees at Cresco Lab’s Sunnyside dispensary petitioned to unionize, they cited a slow and inadequate response to the COVID-19

[myway420]

✌️💚

[crohnic-blog]

Been trying Cresco Labs for the part few days.  So far, really impressed.  

[nikkisnugs]

A whopping 97.61% on an Indica is what I like to see 👀. This hard hitting @crescolabs Bio-Jesus doesn't disappoint. Did someone say Gumbo? 🤤💚 . . . #nikkisnugs #cannabiscommunity #crescolabs #crescodabs #biojesus #nomnomnom #cannabissociety #cannabis #weed #420 #homegrown #iloveweed #womenofcannabis #womenwhoweed #gumbo #bubblegum #THC #dabbingqueen #ilovegrowingmarijuana #710 #livesugar #indica #sugar #hashtag #fuckyeah #cannabispatient #97percent (at Illinois) https://www.instagram.com/p/CESGDPHsct8/?igshid=1txuyr9ari5w1

[nikkisnugs]

A whopping 97.61% on an Indica is what I like to see 👀. This hard hitting @crescolabs Bio-Jesus doesn't disappoint. Did someone say Gumbo? 🤤💚 . . . #nikkisnugs #cannabiscommunity #crescolabs #crescodabs #biojesus #nomnomnom #cannabissociety #cannabis #weed #420 #homegrown #iloveweed #womenofcannabis #womenwhoweed #THC #dabbingqueen #ilovegrowingmarijuana #710 #indica #sugar #hashtag #fuckyeah #cannabispatient #97percent https://www.instagram.com/p/CESGDPHsct8/?igshid=cmxrq2s8sfk9

[itswallstreetpr]

Why MJ Stocks are Back in Gear (GRWG, NUGS, CRLBF, MJNA)

The recent resurgence of the cannabis stock space has been a surprising development to many market participants. Sentiment on this group was already in the basement before the pandemic panic took hold of the markets and crashed the whole game. But pot stocks found support in mid-March as a group. Since then, the MJ ETF is up nearly 50%, and a quick survey of leading names will show a series of aggressive bounces and a few breakouts of significant size and force. We would cite several factors behind the move, including cyclical inflection, seasonal cannabis pricing effects, the pandemic lockdown cabin fever, and expanded market share for the survivors after many stocks in the space failed to survive the depths of the bear. In short, these stocks were completely washed out after two years of bear market action, only to take another huge hit in March when the broad market was obliterated. But, just on the other side of that crash, they ran into an improving demand context, a shortage of supply, and reduced competition. The result has been an impressive rebound that could well represent the dawning of a brand new cannabis bouncing baby bull market trend still in diapers and a bonnet. There’s so much to look forward to: skepticism and short interest, unexpected growth, surprise M&A deals, new analyst attention, big IPO’s, and eventually a supernova of hype, scandal, and nose-bleed valuations that leave latecomers with a bag to hold. But that’s all down the road. Now, traders and investors have a chance to go shopping when these stocks are still unloved but just getting traction to the upside. With that in mind, we present here a brief look at some of the smaller-cap names in the space that are sparking the most interest among traders in recent days: GrowGeneration Corp (NASDAQ:GRWG), Cannabis Strategic Ventures (OTCMKTS:NUGS), Cresco Labs Inc (OTCMKTS:CRLBF), and Medical Marijuana Inc (OTCMKTS:MJNA).     GrowGeneration Corp (NASDAQ:GRWG) has been putting up strong numbers in recent updates from the company, and the stock has been reacting well, surging as much as 100% from its March lows in the past two months. The company managed to rope in revenues totaling $33M in overall sales during the company's most recently reported quarterly financial data -- a figure that represents a rate of top line growth of 152%, as compared to year-ago data in comparable terms. If there’s any concerns here from a fundamental metric perspective, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($11.4M against $17.3M, respectively). GrowGeneration Corp (OTCMKTS:GRWG) trumpets itself as a company that, through its subsidiaries, owns and operates retail hydroponic and organic gardening stores in the United States. Currently, GrowGen has 27 stores, and carries and sells thousands of products, including organic nutrients and soils, advanced lighting technology and state of the art hydroponic equipment to be used indoors and outdoors by commercial and home growers. According to company materials, “Our mission is to own and operate GrowGeneration branded stores in all the major states in the US and Canada. Management estimates that roughly 1,000 hydroponic stores are in operation in the US. By 2025 the market is estimated to reach over $30 billion with a compound annual growth.” If you're long this stock, then you're liking how it has responded in recent days as well. GRWG shares have pushed about 27% to the upside on above average trading volume in the past week since releasing Q1 financials.     Cannabis Strategic Ventures (OTCMKTS:NUGS) is one of the fastest growing producers in the California cannabis market, with a record performance in April, where it saw an 800% sequential gain over calendar Q1 numbers to sell out of its inventory in early May. But the company had anticipated this risk based on a steady acceleration in its new distribution partner agreements, and had already taken steps to more than double its production capacity, with that leap in production now starting to produce fresh cannabis for sale. That suggests coming sales data will continue to show monster second derivative growth throughout Q2. Cannabis Strategic Ventures (OTCMKTS:NUGS) also recently announced that it is about to launch a full line of branded products which are already lined up to be featured through a partnership with one of the fastest growing cannabis delivery services in California. The California cannabis marketplace is seeing a shortage right now, so producers have the best context possible – unless they aren’t in a position to expand production. NUGS, luckily for its shareholders, has been able to scale up to capitalize on the context and drive what looks to be a pretty dramatic topline growth acceleration. Overall, the company’s April data showed an annualized pace exceeding $10 million in sales. “We have never seen anything like this,” noted Simon Yu, CEO of Cannabis Strategic Ventures. “We booked $100,000 in one day to clear out all of our remaining inventory. We anticipated this dynamic but still underestimated the force of the trend. Too much demand is always the problem you want to have. And we are confident we will be able to translate this into further upside in terms of our top line growth curve.”     Cresco Labs Inc (OTCMKTS:CRLBF) is another name recently on the move after a strong catalyst. In this case, the company announced the completion of its expansion project for cultivation and manufacturing at its facility in Brookville, PA. According to that release, the expansion project provides an additional 66,000 square feet of indoor and greenhouse cultivation area, bringing the total cultivation space in the facility to 88,000 square feet. Given the supply issues we are seeing across the country, this move promises to translate directly into a boost for top-line data in the months ahead. This Chicago-based cannabis producer has seen its shares ramp over 100% higher off the March lows, and now sits back where it was in December, with $5/share orders up for grabs. Cresco Labs Inc (OTCMKTS:CRLBF) frames itself as Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells medical cannabis and medical cannabis products in the United States. It offers cannabis in flower, live concentrates, vape, and liquid live resin under the cresco and Reserve brands; precisely-dosed and non-combustible products, including tinctures, capsules, salves, sublingual oils, and transdermal patches under the Remedi brand; culinary-backed under the Mindy's Artisanal brand; fruity confections under the Mindy's Kitchen brand; andpopcorn, shake, pre-rolls, and vapes under High supply brand. It also offers its products under Good News and Wonder brands. As of December 31, 2019, it operated 16 dispensaries in Florida. And the stock has been acting well over recent days, up something like 21% in that time. Cresco Labs Inc (OTCMKTS:CRLBF) pulled in sales of $54.6M in its last reported quarterly financials, representing top line growth of 143.9%. In addition, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($70.2M against $194.7M, respectively).     Medical Marijuana Inc (OTCMKTS:MJNA) shares have been sprinting higher in recent days, helped perhaps by news that Aurora just bought up a CBD producer. Perhaps some folks were hoping that Canopy or Aphria might come along and put in a bid for MJNA given its positioning in the CBD space. Good luck with that. This is not a company that’s going to seem clean under the hood after 20 years of chronic dilution and promotional hype. None of its financial data is regularly audited. And management has chosen to keep it on the pink sheets, where transparency and regulatory hurdles are set at the lowest bar.  So, on the M&A front, we wouldn’t advise holding one’s breath. Medical Marijuana Inc (OTCMKTS:MJNA) bills itself as an investment holding company that operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries. The company licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry. It engages in the research and development of cannabinoid-based pharmaceuticals; and marketing and distribution of cannabidiol hemp oil-based products. In addition, the company provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics; and consulting and securities services to businesses and individuals in the legal cannabis industry. Medical Marijuana Inc (OTCMKTS:MJNA) generated sales of $16.9M, according to information released in the company's most recent quarterly financial report. That adds up to a sequential quarter-over-quarter growth rate of -4.5% on the top line. In addition, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($6.2M against $11M, respectively). Read the full article

[itswallstreetpr]

The Cannabis Resurgence: Five Stocks to Watch (TLRY, SGMD, HRVSF, CRLBF, APHA)

The cannabis space is undeniably in a turnaround phase. Individual names in the space have been establishing a series of higher highs and higher lows defining new upward trends. And the space is still moving under the radar in terms of crowd speculation. That’s generally the best scenario when it comes to identifying sector-based opportunities. The crowd gets involved in the final stage of a trend. The big gains are to be made by being early, when the action shows promise, the big fundamental factors are in second-derivative improvement trends, and the speculative money is still out of the picture. That’s the “buy”. The “sell” is when all the headlines celebrate the great action and the big opportunity, and your next door neighbor is talking about it. Cannabis is in that sweet spot “buy” zone right now, in terms of the sentiment cycle. Hence, it may pay to take note and make a short list of top candidates with promising underlying fundamental trends. With that in mind, here are a few names to put on your list: Tilray Inc (NASDAQ:TLRY), Sugarmade Inc (OTCMKTS:SGMD), Harvest Health & Recreation Inc (OTCMKTS:HRVSF), Cresco Labs Inc (OTCMKTS:CRLBF), and Aphria Inc (NYSE:APHA).   Tilray Inc (NASDAQ:TLRY) engages in the research, cultivation, processing, and distribution of medical cannabis. This is one of the highest profile names in the space. But if you look under the surface, it may also be the weakest because of the crushing burden of its debt-servicing costs at this point. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. was incorporated in 2018 and is headquartered in Nanaimo, Canada. One of its key subsidiaries is High Park, which was launched to produce and distribute world-class cannabis brands and products for the Canadian market. Based in Toronto and led by a team with deep experience in cannabis and global consumer brands, High Park has secured the exclusive rights to produce and distribute a broad-based portfolio of cannabis brands and products in Canada, subject to applicable laws and regulations. And the stock has been acting well over recent days, up something like 18% in that time. Shares of the stock have powered higher over the past month, rallying roughly 36% in that time on strong overall action. Tilray Inc (NASDAQ:TLRY) generated sales of $46.9M, according to information released in the company's most recent quarterly financial report. That adds up to a sequential quarter-over-quarter growth rate of -8.2% on the top line. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($96.8M against $92.4M).   Sugarmade Inc (OTCMKTS:SGMD) is a stock that deserves a close look right now because it appears to be establishing itself as a leader in the California cannabis delivery market through its controlling position in the BudCars juggernaut. BudCars is an emerging delivery leader with a couple hub locations in the Sacramento area. But the company is also in the process of expanding into the massive Los Angeles marketplace, which is particularly interesting given the announcement this week by LA county officials to expand the county’s stay-at-home policy until at least the end of the July. Stay-at-home is a monstrous boon for cannabis delivery on a thematic basis, which should now help to power fresh enthusiasm for SGMD shares. In addition, the company just announced record growth data for the month of April, with sales growing 58% on a sequential monthly basis over March sales on an average daily volume basis. In addition, data for the month of May already show a strong continuation of that trend, with May sales on pace to add another 16% over and above the strong breakout sales trend seen in April. “We did about $6,000 per day in sales in March and over $9,500 per day in April, representing a very robust growth trend at our Sacramento hub,” commented Jimmy Chan, CEO of Sugarmade. “May is already off and running at better than $11,000 per day, demonstrating continued dramatic growth. And investors should also note that this $11,000 per day figure represents activity in only one area. With our LA hub set to come online at the start of summer, and with the unprecedented stay-at-home extension in that region, we believe our daily sales in the LA area could triple that figure relatively quickly.” BudCars is undertaking an expansion in headcount to meet the current and anticipated sharp expansion in demand. SGMD now anticipates the upward shift in sales growth to help solidify its $30 million 2020 revenue target as a conservative target for sales this year.   Harvest Health & Recreation Inc (OTCMKTS:HRVSF) and its affiliates intend to sell a portfolio of equity and assets with respect to 13 operational and planned dispensaries in California to High Times for total consideration including up to $5 million in cash, $7.5 million as a one-year promissory note with 10% interest, and $67.5 million in Series A Preferred Stock issued by High Times. That’s big news powering the stock in recent action. According to the company’s communications on the deal, Harvest will retain select retail dispensaries and licenses for potential retail locations in California following completion of this transaction. Harvest Health & Recreation Inc. is one of the first consistently profitable, vertically integrated cannabis companies with one of the largest footprints in the U.S. Harvest’s complete vertical solution includes industry-leading cultivation, manufacturing, and retail facilities, construction, real estate, technology, operational, and brand building expertise — leveraging in-house legal, HR and marketing teams, along with proven experts in writing and winning state-based applications. The company has more than 525 employees with proven experience, expertise and knowledge of in-house best practices that are drawn upon whenever Harvest enters new markets. Harvest’s executive team is comprised of leaders in finance, compliance, real estate and operations. Harvest Health & Recreation Inc (OTCMKTS:HRVSF) managed to rope in revenues totaling $49.9M in overall sales during the company's most recently reported quarterly financial data -- a figure that represents a rate of top line growth of 123%, as compared to year-ago data in comparable terms. In addition, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($39.8M against $76.9M, respectively).   Cresco Labs Inc (OTCMKTS:CRLBF) trumpets itself as a company that manufactures and sells medical cannabis products in the United States. It offers cannabis dry flower; vaporizer forms of cannabis; cannabis oil in capsule, oral and sublingual solutions; cannabis in topical; and other cannabis products. The company also provides cannabis infused edibles, including chocolate and toffee confections, fruit-forward gummies, and hard sweet and chews. Cresco Labs Inc. sells its products under the Cresco brand. In addition, it operators a Hope Heal Health dispensary in Fall River, Bristol County, Massachusetts. Shares have been acting well over the past five days, up about 9% in that timeframe. Cresco Labs Inc (OTCMKTS:CRLBF) pulled in sales of $54.6M in its last reported quarterly financials, representing top line growth of 143.9%. In addition, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($70.2M against $194.7M, respectively).   Aphria Inc (OTCMKTS:APHQF) is probably the best fundamental value opportunity according to standard calculations employed by fund managers in the space. Most importantly, the stock is trading at about 1.7x sales with a strong balance sheet. The Company’s portfolio of brands is grounded in expertly-researched consumer insights designed to meet the needs of every consumer segment. “Rooted in our founders’ multi-generational expertise in commercial agriculture, Aphria drives sustainable long-term shareholder value through a diversified approach to innovation, strategic partnerships and global expansion, with a presence in more than 10 countries across 5 continents.” The company touts itself as one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. The company is truly powered by sunlight, allowing for the most natural growing conditions available. “We are committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders. We are the first public licensed producer to report positive cash flow from operations and the first to report positive earnings in consecutive quarters.” Aphria Inc (NYSE:APHA) pulled in sales of $120.2M in its last reported quarterly financials, representing top line growth of 454.5%. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($497.7M against $152.5M). Read the full article